Reversitol Recall

A recall was announced on Friday for the dietary supplement Reversitol, which was marketed “for promoting hormonal regulation…,” and contains 6-Etioallochol-1,4-Diene-3,17-Dione, also known as ATD, an aromatase inhibitor.”

The recall is the result of concerns the FDA had on two levels. First, the FDA believed Reversitol does not meet the definition of a dietary ingredient. But the FDA also had more practical concerns about adverse events associated with the use of aromatase inhibitors: decreased rate of bone maturation and growth, decreased sperm production, infertility, aggressive behavior, adrenal insufficiency, kidney failure, and liver dysfunction. The manufacturer has not reported any of these adverse events. Of course, this does not mean they were not happened and the consumer never made the connection back to Reversitol.

iForce Nutrition’s Reversitol V2 is not impacted by the recall.